DCOY insider buying and SEC filings, explained
Decoy Therapeutics Inc. · CIK 1615219
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Pharmaceutical Preparations
- State of incorporation
- DE
- Fiscal year end
- Dec 31
- Former names
- Salarius Pharmaceuticals, Inc.; Flex Pharma, Inc.
Insider activity in the last 12 months
Bought
$16K
Insiders who bought
1
Sold (not marked 10b5-1)
$17
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Dec 30, 2025 | Sale | Arnold C. Hanish (Director) sold 27 shares directly and indirectly (by trust) at $0.6400 ($17). Direct holdings down 100% to 0 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 2, 2026 |
| Nov 20, 2025 | Purchase (code P) | Arnold C. Hanish (Director) bought 5,000 shares indirectly (by trust) at about $0.7500 ($4K), reported as a purchase (code P). Holdings by trust up 999%+ to 5,015 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 24, 2025 |
| Nov 20, 2025 | Purchase (code P) | Mark J Rosenblum (CFO) bought 20,000 shares at $0.8000 ($16K), reported as a purchase (code P). Holdings up 999%+ to 20,177 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 20, 2025 |
10 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow DCOY in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.